BALTIMORE, Md. -- August 3, 2026 Medifast reported second-quarter 2026 revenue of 76.4 million dollars for its Optavia business, with revenue per active earning coach of 6,529 dollars and 11,700 independent active earning coaches. Net loss was 3.1 million dollars, or 0.28 dollars per diluted shar...
BALTIMORE, Md. -- July 17, 2026 Medifast said it is rebranding OPTAVIA, its lifestyle brand and wholly owned subsidiary, as Trilivy, describing the new identity as a science-backed metabolic health system. The company said Trilivy is organized as a three-phase approach labeled Reset, Refine and R...
BALTIMORE, Md. -- May 26, 2026 Medifast said its board has appointed President Nicholas Johnson as chief executive officer effective June 1, 2026, completing the succession plan announced in January when Dan Chard said he would move to non-executive chairman. Johnson's offer letter sets annual ba...
BALTIMORE, Md. -- May 4, 2026 Medifast, the parent of Optavia, reported first-quarter 2026 revenue of 76.0 million dollars, down 34.3% from 115.7 million dollars a year earlier, as the number of independent active earning coaches fell. Active earning coaches declined 44.9% to 14,000, while revenu...
BALTIMORE, Md. -- March 20, 2026 Medifast, the parent of Optavia, said its board has agreed to nominate Parsa Kiai and Jeff Rose of Steamboat Capital Partners as independent director candidates at its 2026 annual meeting, provisionally scheduled for May 19, 2026, under a cooperation agreement wit...
BALTIMORE, May 1, 2023 -- Medifast, Inc., parent of OPTAVIA, reported first-quarter 2023 revenue of 349.0 million dollars, down 16.4 percent from 417.6 million dollars a year earlier. Independent active earning OPTAVIA Coaches fell 8.1 percent to 58,700, and revenue per active earning coach fell ...
BALTIMORE, February 21, 2023 -- Medifast, Inc., parent of OPTAVIA, reported fourth-quarter 2022 revenue of 337.2 million dollars, down 10.7 percent from 377.8 million dollars a year earlier. Independent active earning OPTAVIA Coaches rose 1.8 percent to 60,900, while revenue per active earning co...
Medifast, parent of the OPTAVIA coach-based weight management brand, reported third-quarter 2022 revenue of 390.4 million dollars, down 5.6 percent from a year earlier. Net income was 36.2 million dollars, or 3.27 dollars per diluted share, compared with 3.56 dollars, and adjusted EPS was 3.32 do...
Medifast, the parent of OPTAVIA, said second-quarter 2022 revenue rose 15.0 percent to 453.3 million dollars. Net income was 39.1 million dollars, or 3.42 dollars per diluted share. Adjusted net income was 44.3 million dollars, or 3.87 dollars per diluted share. Active earning OPTAVIA Coaches ros...
Medifast, the parent of OPTAVIA, said first-quarter 2022 revenue rose 22.6 percent to 417.6 million dollars. Net income was 41.8 million dollars, or 3.59 dollars per diluted share. Active earning OPTAVIA Coaches rose 21.7 percent to 63,900, and revenue per active earning coach rose 1.3 percent to...